ICH E8 General Considerations for Clinical Trials Flashcards
1. Considerations for development plan 2. Basic trial design 3. Stages of drug development
Phase 1 type of study
Human pharmacology
Phase 2 type of study
Therapeutic Exploratory
Phase 3 type of study
Therapeutic Confirmatory
Phase 4 type of study
Therapeutic Use
Objective of Phase 1
TAMP Assess Tolerance Estimate Activity Explore Metabolism and drug interactions Define PK/PD
Objective of Phase 2
Explore use of the targeted indication
Estimate dosage for subsequent studies
Provide basis for confirmatory study design, endpoints, methodologies
Objective of Phase 3
Demonstrate/ confirm efficacy
Establish safety profile
Provide and adequate basis for Assessing the benefit/risk relationship to support licensing
Establish dose-response relationship
Objective of Phase 4
Refine understanding of benefit/risk relationship in general or special populations and/or environments
identify less common adverse reactions
refine dosing recommendation
Dose Tolerance Study
Phase 1
Single and multiple dose PK and or PD studies
Phase 1
Drug interaction studies
Phase 1
Trials in relatively short duration, well defined narrow patient populations using surrogate or pharmacologic endpoints or clinical measures
Phase 2
Dose-response exploration studies
Phase 2
Well controlled studies to establish efficacy
Phase 3
Randomized parallel dose-response studies
Phase 3